Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2011
08/18/2011CA2789195A1 Derivatives of betulin
08/18/2011CA2788400A1 Antibodies against cxcr4
08/18/2011CA2787990A1 Nucleic acid complexes
08/18/2011CA2786973A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/18/2011CA2786550A1 Removal of virulence factors through extracorporeal therapy
08/17/2011EP2357200A1 Human antibodies that bind human TNFalpha
08/17/2011EP2357198A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/17/2011EP2357187A1 Molecules with extended half-lives, compositions and uses thereof
08/17/2011EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
08/17/2011EP2357008A1 Albumin fusion proteins
08/17/2011EP2357002A1 Nucleic acid molecules and polypeptides for immune modulation
08/17/2011EP2357001A1 Regimens for immunisation with meningococcal conjugates
08/17/2011EP2356994A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/17/2011EP2356991A1 Use of bacteria of the genus tenacibaculum for quorum quenching
08/17/2011EP2356990A2 Liposome treatment of viral infections
08/17/2011EP2356236A1 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION
08/17/2011EP2356225A1 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
08/17/2011EP2356093A1 Carbazole compounds and therapeutic uses of the compounds
08/17/2011EP2355848A2 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases
08/17/2011EP2355832A2 Compositions and methods for treating retrovirus infections
08/17/2011EP2355831A1 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer
08/17/2011EP2355816A2 Novel uses
08/17/2011EP2355807A1 Inhibitors of dimethylarginine dimethylaminohydrolase
08/17/2011EP2355800A1 Nanoparticles of beta-lactam derivatives
08/17/2011EP2167494B1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
08/17/2011EP2087899B1 Grifola frondosa-derived substance having anti-influenza virus activity and method for producing the same
08/17/2011EP1976561B1 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type
08/17/2011EP1687295B1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
08/17/2011EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
08/17/2011EP1246808B1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
08/17/2011CN1910154B Quinoline derivatives for use as mycobacterial inhibitors
08/17/2011CN1894236B Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/17/2011CN102159582A Oxazolopyrimidines as edg-1 receptor agonists
08/17/2011CN102159579A Tricyclic indole derivatives and methods of use thereof
08/17/2011CN102159576A Improved production method for adefovir dipivoxil
08/17/2011CN102159571A Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, potent hcv inhibitor
08/17/2011CN102159566A Pyridone and pyridazone analogues as gpr119 modulators
08/17/2011CN102159537A Organic compounds for applications in bacterial infections treatment
08/17/2011CN102159531A Cyclohexenyl modulators of chemokine receptor activity
08/17/2011CN102159285A Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
08/17/2011CN102159241A Tapasin augmentation for enhanced immune response
08/17/2011CN102159231A Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
08/17/2011CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
08/17/2011CN102159221A Anti-infective formulation and methods of use
08/17/2011CN102154367A Swine influenza virus H3N2 and H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
08/17/2011CN102154366A Swine influenza virus H3N2 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
08/17/2011CN102154365A Swine influenza virus H1N1 subtype hemagglutinin (HA)-1 protein recombinant suipoxvirus and preparation method thereof
08/17/2011CN102154348A Vibrio anguillarum and edwardsiella tarda-resistant multi-valence live vaccine, correlative expression vector and application
08/17/2011CN102154325A Vaccine against human papillomavirus (HPV) as well as preparation method and application thereof
08/17/2011CN102154324A Construction method of mycobacterium tuberculosis fusion protein Mtb 10.4-Hsp16.3, expression method thereof, purification method thereof and application thereof
08/17/2011CN102154307A Method for preparing recombinant chicken beta-interferon and application thereof
08/17/2011CN102154293A Small-interfering RNA (siRNA) capable of inhibiting classical swine fever virus (CSFV) reproduction and infection as well as preparation method and application thereof
08/17/2011CN102154290A SiRNAs for inhibiting epidemic encephalitis B viruses
08/17/2011CN102154229A EV71 virus-like particles and hand-foot-and-mouth disease vaccine prepared from EV71 virus-like particles
08/17/2011CN102154224A Construction of recombinant chicken marek's disease vaccine virus SC9-1 strain and application thereof
08/17/2011CN102154220A Method and equipment for ultrahigh-density and large-scale production of porcine reproductive and respiratory syndrome virus (PRRSV)
08/17/2011CN102154219A Swine influenza A H1N1 virus and use thereof
08/17/2011CN102154206A Preparation method of high-purity, high-multiplication capacity and high-cytotoxin activity CIK (cytokine induced kill) cell
08/17/2011CN102154205A Method for preparing high-purity and high-cytotoxin-activity gamma delta T cells
08/17/2011CN102154184A Attenuated Salmonella pullorum and application thereof
08/17/2011CN102154176A Turbot pathogenic strain and inactivated vaccine for ascites disease
08/17/2011CN102153656A Vaccine for chimeric virus-like particles and preparation method thereof
08/17/2011CN102153654A Branched polypeptide using immune active peptide as vector and derivatives and application of branched polypeptide
08/17/2011CN102153632A Antibody of escherichia coli resistant TolC tricosanoic peptide and application
08/17/2011CN102153631A Antimicrobial protein with high-efficiency sterilizing activity and application thereof
08/17/2011CN102153626A Short peptide with bacteriostatic activity and application thereof
08/17/2011CN102153621A B-cell epitope of NA-protein for new influenza A (H1N1) and application thereof
08/17/2011CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof
08/17/2011CN102153577A 2-seleno-N-pyridine oxide-rare earth metal ion compound and preparation method and application thereof
08/17/2011CN102153575A Dioxane-coordinated rare-earth coordination compound, and preparation method and application thereof
08/17/2011CN102153555A Carbapenem compound containing amido formacyl heterocycle
08/17/2011CN102153553A Oral administration carbapenem compound containing amino sulfonamide-azetidine
08/17/2011CN102153547A Oxazolidinone antibiotic containing parallel rings
08/17/2011CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/17/2011CN102153538A Benzocyclodirivative
08/17/2011CN102153534A Compound with tyrosinase inhibitory activity as well as preparation method and application thereof
08/17/2011CN102153533A 3-nitro-2H-chromene compounds with antibacterial activity and preparation method and application thereof
08/17/2011CN102153532A Application of eriosema chinense isoflavone compound
08/17/2011CN102153524A Polymorph of a pharmaceutical
08/17/2011CN102153517A Diaryl pyrimidone hydrazone derivatives and preparation method and application of diaryl pyrimidone hydrazone derivatives
08/17/2011CN102153504A Method for preparing 1-deoxynojirimycin in mulberry leaves
08/17/2011CN102153492A Treatment medicament for resisting infectious diseases, and preparation method and application thereof
08/17/2011CN102151335A Regulation of metabolism by protein lysine acetylation modification
08/17/2011CN102151333A Vaccination against host cell-associated herpesviruses
08/17/2011CN102151332A Helicobacter pylori epitope vaccine, design method thereof, preparation method thereof and application thereof
08/17/2011CN102151331A Polysaccharide-protein conjugate vaccines
08/17/2011CN102151322A Chinese medicine composition for treating cold in children, preparation method and detection method thereof
08/17/2011CN102151308A Traditional Chinese medicinal pulvis for treating dry cholera
08/17/2011CN102151302A Rhubarb liposome for external use, and preparation method and application thereof
08/17/2011CN102151295A Preparation method of medicine for preventing and curing poultry viral disease and application of medicine
08/17/2011CN102151292A Preparation method of total flavone from natural plant
08/17/2011CN102151290A Preparation method of poultry specific transfer factors
08/17/2011CN102151288A Compound for preventing and controlling porcine virus diseases
08/17/2011CN102151283A Compound medicament for preventing and treating chicken diseases
08/17/2011CN102151278A Use of 2-deoxy-D-glucose in prevention and treatment of viral diseases in livestock
08/17/2011CN102151270A Pyrimidine derivatives for the prevention of HIV infection
08/17/2011CN102151269A Composition for treating pig paratyphus and preparation method thereof
08/17/2011CN102151267A Tablet capsule for curing tuberculosis
08/17/2011CN102151266A Oral liquid for treating white scour of chicken and preparation method thereof
08/17/2011CN102151263A Veterinary compound hydrochloric acid injection and preparation method thereof